UCLA cancer research Dr. Tanya Stoyanova
Dr. Tanya Stoyanova (right) in her lab. She and her research team are developing new early detection approaches and therapeutic strategies for late stage cancers.

Below are funding resources from the National Institutes of Health (NIH), the UCLA Health Jonsson Comprehensive Cancer Center and UCLA. For more information on UCLA Health JCCC-related funding opportunities, please visit our Internal Funding and External Funding pages.

NIH Funding Resources

NIH Grants and Funding Search Guide

UCLA Health Jonsson Comprehensive Cancer Center Funding Resources

Extramural Quarterly Funding Announcement

The UCLA Health JCCC provides an Extramural Quarterly Funding Announcement for UCLA investigators. This includes currently open extramural funding opportunities that are of interest to UCLA investigators. it is emailed directly to members. 

Extramural Limited Submission Funding Opportunities

Limited extramural funding opportunities are provided below as a courtesy to UCLA Health JCCC members. For an opportunity to be included on this list, it must be a cancer-relevant Limited Submission Opportunity (LSO). LSOs for NIH Administrative Supplements responsive to the UCLA Health JCCC’s Support Grant, P30CA016042, are also included on this list. Submission instructions are noted below. 

For more information, please visit our online funding portal, InfoReady. Here, you can find detailed information about available LSOs and explore the home page for more opportunities. If you have any questions about specific LSOs listed below or about NIH Administrative Supplements (under UCLA Health JCCC’s Support Grant, P30CA016042), please contact Sarah Anwar Tar via email.

InfoReady Portal

Current LSOs

NCI Research Specialist (Clinician Scientist) Award

The Research Specialist (Clinician Scientist) Award is intended to provide salary support and sufficient autonomy so that individuals are not solely dependent on NCI-funded grants held by others or other sources of support for cancer research career continuity. Over the past decade, cancer clinical trials have become more complex in trial design, have a greater number of regulatory issues to address and require significant effort from clinician investigators to review safety data, monitor the progress of multiple ongoing clinical trials, and respond to human subjects concerns that are both expected and unexpected. These efforts are frequently not reimbursed and are neither funded in research project grants nor funded through the NCI clinical trials networks. Typical research activities include service on institutional clinical research committees (institutional review boards, protocol review and monitoring for scientific prioritization, data safety, and management, disease- or modality-based disease groups, etc.), oversight of multiple clinical trials within a clinical trials office, service on national clinical trials committees (National Clinical Trials Network steering committees, etc.), developing new cancer clinical trials by writing and revising new protocols, recruiting patients to new and existing trials, and satisfying annual training in human subjects protection and regulatory compliance. The need for individuals with the broad research expertise and clinical background required of clinician scientists is rapidly growing. Current sources of support for the research activities of clinician scientists are inadequate and compete against the growing demands of clinical duties and responsibilities.

How to apply
To submit your nomination application, please access our NCI Research Specialist online application via InfoReady.

Deadline
Please submit a one-page research summary and a current NIH Biosketch by Thursday, October 9, 2025 at 5pm PST.

UCLA Funding Resources

We Want to Hear from You!

Help us improve your experience with our services! Click the Take Survey button to take a short three-question survey.